229 related articles for article (PubMed ID: 32187043)
1. Spectrum of Hepatic Manifestations of Common Variable Immunodeficiency.
Crotty R; Taylor MS; Farmer JR; Kakar S; Yilmaz F; Ardeniz Ö; Patil DT; Deshpande V
Am J Surg Pathol; 2020 May; 44(5):617-625. PubMed ID: 32187043
[TBL] [Abstract][Full Text] [Related]
2. Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia.
DiGiacomo DV; Shay JE; Crotty R; Yang N; Bloom P; Corey K; Barmettler S; Farmer JR
Front Immunol; 2022; 13():864550. PubMed ID: 35603209
[TBL] [Abstract][Full Text] [Related]
3. Nodular regenerative hyperplasia in common variable immunodeficiency.
Fuss IJ; Friend J; Yang Z; He JP; Hooda L; Boyer J; Xi L; Raffeld M; Kleiner DE; Heller T; Strober W
J Clin Immunol; 2013 May; 33(4):748-58. PubMed ID: 23420139
[TBL] [Abstract][Full Text] [Related]
4. Liver disease accompanied by enteropathy in common variable immunodeficiency: Common pathophysiological mechanisms.
Lima FMS; Toledo-Barros M; Alves VAF; Duarte MIS; Takakura C; Bernardes-Silva CF; Marinho AKBB; Grecco O; Kalil J; Kokron CM
Front Immunol; 2022; 13():933463. PubMed ID: 36341360
[TBL] [Abstract][Full Text] [Related]
5. [Nodular regenerative hyperplasia associated with common variable immunodeficiency and other comorbidities].
León R; Sánchez-Martínez R; Palazón JM; Payá A; Ramos JM; Pinargote H
Med Clin (Barc); 2016 Mar; 146(6):263-6. PubMed ID: 26723943
[TBL] [Abstract][Full Text] [Related]
6. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
Navale P; Gonzalez RS
Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis in common variable immunodeficiency.
Daniels JA; Torbenson M; Vivekanandan P; Anders RA; Boitnott JK
Hum Pathol; 2009 Apr; 40(4):484-8. PubMed ID: 19084266
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis.
Dhingra S; Mahadik JD; Tarabishy Y; May SB; Vierling JM
Pathology; 2022 Oct; 54(6):686-693. PubMed ID: 35525796
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.
Daza-Cajigal V; Segura-Guerrero M; López-Cueto M; Robles-Marhuenda Á; Camara C; Gerra-Galán T; Gómez-de-la-Torre R; Avendaño-Monje CL; Sánchez-Ramón S; Bosque-Lopez MJ; Quintero-Duarte A; Bonet-Vidal ML; Pons J
Front Immunol; 2023; 14():1197361. PubMed ID: 37342345
[TBL] [Abstract][Full Text] [Related]
11. Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of death.
Halliday N; Eden N; Somers H; Burke N; Silva H; Brito CG; Hall A; Quaglia A; Burns SO; Lowe DM; Thorburn D
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38099861
[TBL] [Abstract][Full Text] [Related]
12. Common variable immunodeficiency disorder (CVID)-related liver disease: assessment of the main histological aspects using novel semiquantitative scoring systems, image analysis and correlation with clinical parameters of liver stiffness and portal hypertension.
Silva H; Brito CGX; Hall A; Eden N; Somers H; Burke N; Burns SO; Lowe D; Thorburn D; Halliday N; Quaglia A
J Clin Pathol; 2023 Aug; ():. PubMed ID: 37553247
[TBL] [Abstract][Full Text] [Related]
13. Common Variable Immunodeficiency and Liver Involvement.
Song J; Lleo A; Yang GX; Zhang W; Bowlus CL; Gershwin ME; Leung PSC
Clin Rev Allergy Immunol; 2018 Dec; 55(3):340-351. PubMed ID: 28785926
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of non-cirrhotic portal hypertension in patients with common variable immunodeficiency].
Wu J; Han XX; Di H; Yin Y; Han YD; Wang Y; Zhang Y; Zeng XJ
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):1007-1011. PubMed ID: 37528040
[TBL] [Abstract][Full Text] [Related]
15. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
Malamut G; Ziol M; Suarez F; Beaugrand M; Viallard JF; Lascaux AS; Verkarre V; Bechade D; Poynard T; Hermine O; Cellier C
J Hepatol; 2008 Jan; 48(1):74-82. PubMed ID: 17998147
[TBL] [Abstract][Full Text] [Related]
16. Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients.
Hanitsch LG; Steiner S; Schumann M; Wittke K; Kedor C; Scheibenbogen C; Fischer A
Front Immunol; 2023; 14():1268207. PubMed ID: 38187397
[TBL] [Abstract][Full Text] [Related]
17. Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction.
Vallonthaiel AG; Baloda V; Singh L; Yadav R; Kilambi R; Battu S; Sreenivas V; Pal S; Acharya SK; DattaGupta S; Shalimar ; Das P
Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S127-S135. PubMed ID: 34135154
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.
Daniels JA; Lederman HM; Maitra A; Montgomery EA
Am J Surg Pathol; 2007 Dec; 31(12):1800-12. PubMed ID: 18043034
[TBL] [Abstract][Full Text] [Related]
19. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis.
Colina F; Pinedo F; Solís JA; Moreno D; Nevado M
Gastroenterology; 1992 Apr; 102(4 Pt 1):1319-24. PubMed ID: 1551537
[TBL] [Abstract][Full Text] [Related]
20. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.
Ward C; Lucas M; Piris J; Collier J; Chapel H
Clin Exp Immunol; 2008 Sep; 153(3):331-7. PubMed ID: 18647320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]